CYH · Community Health Systems Inc - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $12.48B | $12.63B | $12.49B | $12.21B | $12.37B | $11.79B |
| Cost of Revenue | $1.86B | $1.95B | $1.99B | $1.98B | $2.04B | $1.96B |
| Gross Profit | $10.62B | $10.69B | $10.50B | $10.24B | $10.33B | $9.83B |
| R&D | - | - | - | - | - | - |
| SG&A | - | - | - | - | - | - |
| Total Operating Expenses | $11.00B | $12.09B | $11.53B | $11.39B | $10.97B | $10.66B |
| D&A | $426.00M | $486.00M | $505.00M | $534.00M | $540.00M | $558.00M |
| Operating Income | $1.49B | $542.00M | $957.00M | $821.00M | $1.40B | $1.13B |
| Interest Expense | - | - | - | - | - | - |
| Income Tax | $48.00M | $79.00M | $191.00M | $170.00M | $131.00M | ($185.00M) |
| Net Income | $509.00M | ($516.00M) | ($133.00M) | $46.00M | $230.00M | $511.00M |
| EPS - Basic | $3.81 | ($3.90) | ($1.02) | $0.35 | $1.82 | $4.43 |
| EPS - Diluted | $3.77 | ($3.90) | ($1.02) | $0.35 | $1.76 | $4.39 |
Balance Sheet
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $260.00M | $37.00M | $38.00M | $118.00M | $507.00M | $1.68B |
| Accounts Receivable | $2.08B | $2.29B | $2.23B | $2.04B | $2.06B | $1.93B |
| Inventory | - | - | - | - | - | - |
| Accounts Payable | $842.00M | $913.00M | $912.00M | $773.00M | $830.00M | $783.00M |
| Current Assets | $3.23B | $3.30B | $3.21B | $3.08B | $3.48B | $4.51B |
| Total Assets | $13.20B | $14.05B | $14.46B | $14.67B | $15.22B | $16.01B |
| Current Liabilities | $2.21B | $2.35B | $2.14B | $2.19B | $2.36B | $2.81B |
| Long-term Debt | $10.38B | $11.43B | $11.47B | $11.61B | $12.11B | $12.09B |
| Total Liabilities | $14.04B | $15.37B | $15.28B | $15.40B | $16.03B | $17.06B |
| Stockholders' Equity | ($1.39B) | ($1.91B) | ($1.39B) | ($1.37B) | ($1.37B) | ($1.63B) |
| Retained Earnings | ($3.57B) | ($4.08B) | ($3.56B) | ($3.43B) | ($3.48B) | ($3.71B) |
Cash Flow
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | $543.00M | $480.00M | $210.00M | $300.00M | ($131.00M) | $2.18B |
| Investing Cash Flow | $847.00M | ($275.00M) | ($26.00M) | ($259.00M) | ($524.00M) | $177.00M |
| Financing Cash Flow | ($1.17B) | ($206.00M) | ($264.00M) | ($430.00M) | ($514.00M) | ($895.00M) |
| CapEx | $335.00M | $360.00M | $467.00M | $415.00M | $469.00M | $440.00M |
| Free Cash Flow | $208.00M | $120.00M | ($257.00M) | ($115.00M) | ($600.00M) | $1.74B |
Ratios
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 85.1% | 84.6% | 84.0% | 83.8% | 83.5% | 83.3% |
| Operating margin | 11.9% | 4.3% | 7.7% | 6.7% | 11.3% | 9.6% |
| EBITDA margin | 15.3% | 8.1% | 11.7% | 11.1% | 15.7% | 14.3% |
| Net margin | 4.1% | -4.1% | -1.1% | 0.4% | 1.9% | 4.3% |
| Free cash flow margin | 1.7% | 0.9% | -2.1% | -0.9% | -4.9% | 14.7% |
| FCF / Net income | 0.41 | -0.23 | 1.93 | -2.50 | -2.61 | 3.40 |
| R&D / Revenue | - | - | - | - | - | - |
| SG&A / Revenue | - | - | - | - | - | - |
| Effective tax rate | 8.6% | - | 329.3% | 78.7% | 36.3% | -56.7% |
| Return on assets | 3.9% | -3.7% | -0.9% | 0.3% | 1.5% | 3.2% |
| Return on equity | -36.5% | 27.0% | 9.6% | -3.4% | -16.8% | -31.4% |
| Return on invested capital | 15.1% | 4.5% | 4.7% | 4.0% | 8.3% | 10.8% |
| Liquidity | ||||||
| Current ratio | 1.46 | 1.41 | 1.50 | 1.41 | 1.47 | 1.60 |
| Quick ratio | 1.46 | 1.41 | 1.50 | 1.41 | 1.47 | 1.60 |
| Cash ratio | 0.12 | 0.02 | 0.02 | 0.05 | 0.21 | 0.60 |
| Leverage | ||||||
| Debt / Equity | -7.45 | -5.97 | -8.24 | -8.50 | -8.83 | -7.44 |
| Debt / Assets | 0.79 | 0.81 | 0.79 | 0.79 | 0.80 | 0.76 |
| Debt / EBITDA | 5.42 | 11.12 | 7.84 | 8.57 | 6.24 | 7.18 |
| Interest coverage | - | - | - | - | - | - |
| Equity multiplier | -9.47 | -7.34 | -10.38 | -10.73 | -11.09 | -9.85 |
| Liabilities / Assets | 1.06 | 1.09 | 1.06 | 1.05 | 1.05 | 1.07 |
| Efficiency | ||||||
| Asset turnover | 0.95 | 0.90 | 0.86 | 0.83 | 0.81 | 0.74 |
| Inventory turnover | - | - | - | - | - | - |
| Days sales outstanding | 61d | 66d | 65d | 61d | 61d | 60d |
| Days inventory outstanding | - | - | - | - | - | - |
| Days payable outstanding | 165d | 171d | 167d | 143d | 148d | 146d |
| Cash conversion cycle | - | - | - | - | - | - |
| Valuation | ||||||
| P / E | 0.8x | - | - | 12.3x | 7.6x | 1.7x |
| P / B | - | - | - | - | - | - |
| P / S | 0.0x | 0.0x | 0.0x | 0.0x | 0.1x | 0.1x |
| EV / EBITDA | 5.5x | 11.5x | 8.1x | 8.9x | 6.9x | 6.7x |
| Growth | ||||||
| Revenue growth (YoY) | -1.2% | 1.2% | 2.3% | -1.3% | 4.9% | -10.8% |
| Revenue CAGR (3y) | 0.7% | 0.7% | 1.9% | -2.6% | -12.5% | - |
| Revenue CAGR (5y) | 1.2% | -0.9% | -7.5% | - | - | - |
| Gross profit growth (YoY) | -0.6% | 1.8% | 2.5% | -0.9% | 5.1% | -11.1% |
| Operating income growth (YoY) | 174.5% | -43.4% | 16.6% | -41.4% | 24.5% | 73.2% |
| Net income growth (YoY) | - | -288.0% | - | -80.0% | -55.0% | - |
| EPS growth (YoY) | - | -282.4% | - | -80.1% | -59.9% | - |
| EPS CAGR (3y) | 120.8% | - | - | - | - | - |
| EPS CAGR (5y) | -3.0% | - | - | - | - | 26.2% |
| FCF growth (YoY) | 73.3% | - | -123.5% | 80.8% | - | - |
| FCF CAGR (5y) | -34.6% | - | - | - | - | - |
| Book value growth (YoY) | 27.2% | -37.5% | -1.8% | 0.4% | 15.6% | 26.7% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2025-12-31.
Product / service
$12.48B totalManaged Care And Other Third Party Payors$5.97B · 47.9%
Medicare Managed Care$2.25B · 18.0%
Medicare$2.17B · 17.4%
Medicaid$1.99B · 15.9%
Self Pay Revenue$96.00M · 0.8%
Stability scores
Altman Z′
FY 2025 · bankruptcy risk
1.08
Distress
Private-firm variant - uses book equity instead of market cap. > 2.90 safe · 1.23-2.90 grey · < 1.23 distress.
Piotroski F-score
FY 2025 · 9-point quality
8/9
Strong
- ✓Net income positive
- ✓Operating cash flow positive
- ✓ROA improved YoY
- ✓Cash flow > net income
- ✓Long-term debt decreased
- ✓Current ratio improved
- ✗No share dilution
- ✓Gross margin improved
- ✓Asset turnover improved
Peer comparison
Same SIC group: Services-General Medical & Surgical Hospitals, NEC
Comparing COMMUNITY HEALTH SYSTEMS INC against the 5 most active filers in the same SIC group.
Dividends
$0.00/share trailing 12 months
| Ex-date | Per share |
|---|---|
| Dec 13, 2012 | $0.2066 |